Understanding mechanisms of hypertension in systemic lupus erythematosus
Authors:
Open Access
- 31 July 2016
- journal article
- review article
- Published by SAGE Publications in Therapeutic Advances in Cardiovascular Disease
- Vol. 11 (1) , 20-32
Abstract
Systemic lupus erythematosus (SLE) is a chronic autoimmune disorder that predominately affects women of reproductive age. Hypertension is an important cardiovascular risk factor that is prevalent in this patient population. Despite the high incidence of hypertension in women with SLE, the pathophysiological mechanisms underlying the development of hypertension remain poorly understood. This review will focus on disease-related factors, including inflammation, autoantibodies, and sex hormones that may contribute to hypertension in patients with SLE. In addition, we will highlight studies performed by our laboratory using the female NZBWF1 (F1 hybrid of New Zealand Black and New Zealand White strains) mouse model, a spontaneous model of SLE that mimics human disease and develops hypertension and renal injury. Specifically, using female NZBWF1 mice, we have demonstrated that multiple factors contribute to the pathogenesis of hypertension, including the inflammatory cytokine, tumor necrosis factor (TNF)-α, oxidative stress, as well as B-cell hyperactivity and autoantibody production.Keywords
This publication has 126 references indexed in Scilit:
- Blood pressure in a hypertensive mouse model of SLE is not salt-sensitiveAmerican Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 2011
- Blood pressure and renal hemodynamic responses to acute angiotensin II infusion are enhanced in a female mouse model of systemic lupus erythematosusAmerican Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 2011
- T lymphocytes mediate hypertension and kidney damage in Dahl salt-sensitive ratsAmerican Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 2010
- Role of the adaptive immune system in hypertensionCurrent Opinion in Pharmacology, 2010
- Rosiglitazone decreases blood pressure and renal injury in a female mouse model of systemic lupus erythematosusAmerican Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 2009
- Young Investigator Award Lecture of the APS Water and Electrolyte Homeostasis Section, 2008: The pathophysiology of hypertension in systemic lupus erythematosusAmerican Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 2009
- African–American and Hispanic ethnicities, renal involvement and obesity predispose to hypertension in systemic lupus erythematosus: results from LUMINA, a multiethnic cohort (LUMINAXLV)Annals of the Rheumatic Diseases, 2007
- The biology of nitric oxide and other reactive intermediates in systemic lupus erythematosusClinical Immunology, 2006
- ATlr7translocation accelerates systemic autoimmunity in murine lupusProceedings of the National Academy of Sciences, 2006
- Autoreactive B Cell Responses to RNA-Related Antigens Due to TLR7 Gene DuplicationScience, 2006